Trump cabinet members watching their diets with RFK Jr.
Stat News • 2/10/2026
Summary
Trump cabinet members are monitoring their diets alongside RFK Jr. This information is part of health news featured in the Morning Rounds newsletter.
Advertisement
Lindy Score Breakdown (V4.2)
53d
Age
1
Sources
from cluster
1275
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1275/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1275/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 53 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
Biotech investors’ plea to Trump, and a busy M&A week
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Trump tariff plans, FDA’s OK for a Lilly obesity pill, and more
Stat News • 2 days ago
STAT+: Trump administration prepares 100% tariffs on some imported drugs
Stat News • 2 days ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 2 days ago
STAT+: Biotech investors’ plea to Trump, and a busy M&A week
Stat News • 1 day ago
STAT+: NIH would get $5 billion cut under Trump’s 2027 budget, but Congress unlikely to go along
Stat News • 1 day ago
Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 2 days ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago